Proteomics studies of childhood pilocytic astrocytoma

Journal of Proteome Research

Volumn 10, Issue 5, 2011, Pages 2555-2565

  Anagnostopoulos, Athanasios K ^a,b   Dimas, Konstantinos S ^a   Papathanassiou, Chrissa ^b   Braoudaki, Maria ^b   Anastasiadou, Ema ^a   Vougas, Konstantinos ^a   Karamolegou, Kalliopi ^b   Kontos, Harry ^c   Prodromou, Neofytos ^d   Tzortzatou Stathopoulou, Fotini ^b   Tsangaris, George Th ^a  

^a BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c Genomedica Molecular Diagnostics Laboratory   (Greece)

^d AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

pilocytic astrocytoma; proteomics

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1;

ARTICLE; BIOINFORMATICS; CHILD; CHILDHOOD CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; GENOMICS; HUMAN; HUMAN TISSUE; MALE; PILOCYTIC ASTROCYTOMA; PRIORITY JOURNAL; PROTEOMICS;

ASTROCYTOMA; BLOTTING, WESTERN; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; COMPUTATIONAL BIOLOGY; DATABASES, PROTEIN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENOMICS; HUMANS; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; PROTEOME; PROTEOMICS;

EID: 79955809449     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr200024m     Document Type: Article

References (41)

1. Nozaki, M.; Tada, M.; Kobayashi, H.; Zhang, C. L.; Sawamura, Y.; Abe, H.; Ishii, N.; Van Meir, E. G. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression Neuro. Oncol. 1999, 2, 124-137
2. Louis, D. N. International Agency for Research on Cancer. WHO classification of tumours of the central nervous system; International Agency for Research on Cancer: Lyon, 2007.
3. Central Brain Tumor Registry of the United States. Statistical report: primary brain tumors in the United States 1998-2002; 2006.
4. Lantos, P. L.; Vandenberg, S. R.; Kleihues, P. Tumours of the nervous system. Epidemiology and aetiology. In Greinfield's neuropathology, 6 th ed.; Graham, D.I.,; Lantos, P.L., Eds.; Arnold: London, 1997; Vol. 2, pp 583-588.
5. Dirven, C. M.; Mooij, J. J.; Molenaar, W. M. Cerebellar pilocytic astrocytoma: a treatment protocol based upon analysis of 73 cases and a review of the literature Childs Nerv. Syst. 1997, 13, 17-23 (Pubitemid 27104553)
6. Fernandez, C.; Figarella-Branger, D.; Girard, N.; Bouvier-Labit, C.; Gouvernet, J.; Paz Paredes, A.; Lena, G. Pilocytic astrocytomas in children: prognostic factors - a retrospective study of 80 cases Neurosurgery 2003, 3, 544-553
7. White, F. V.; Anthony, D. C.; Yunis, E. J.; Tarbell, N. J.; Scott, R. M.; Schofield, D. E. Non-random chromosomal gains in pilocytic astrocytomas of childhood Hum. Pathol. 1995, 26, 979-986
8. Phizicky, E.; Bastiaens, P. I.; Zhu, H.; Snyder, M.; Fields, S. Protein analysis on a proteomic scale Nature 2003, 6928, 208-215 (Pubitemid 36362758)
9. Sun, W.; Xing, B.; Sun, Y.; Du, X.; Lu, M.; Hao, C.; Lu, Z.; Mi, W.; Wu, S.; Wei, H.; Gao, X.; Zhu, Y.; Jiang, Y.; Qian, X.; He, F. Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues Mol. Cell. Proteomics 2007, 10, 1798-1808 (Pubitemid 350031681)
10. Li, Z.; Zhao, X.; Bai, S.; Wang, Z.; Chen, L.; Wei, Y.; Huang, C. Proteomics identification of cyclophilin a as a potential prognostic factor and therapeutic target in endometrial carcinoma Mol. Cell. Proteomics 2008, 10, 1810-1823
11. Anagnostopoulos, A. K.; Kolialexi, A.; Mavrou, A.; Vougas, K.; Papantoniou, N.; Antsaklis, A.; Kanavakis, E.; Fountoulakis, M.; Tsangaris, G. T. Proteomic analysis of amniotic fluid in pregnancies with Klinefelter syndrome foetuses J. Proteomics 2010, 5, 943-950
12. Mavrou, A.; Anagnostopoulos, A. K.; Kolialexi, A.; Vougas, K.; Papantoniou, N.; Antsaklis, A.; Fountoulakis, M.; Tsangaris, G. T. Proteomic analysis of amniotic fluid in pregnancies with Turner syndrome fetuses J. Proteome Res. 2008, 5, 1862-1866
13. Roessler, M.; Rollinger, W.; Palme, S.; Hagmann, M. L.; Berndt, P.; Engel, A. M.; Schneidinger, B.; Pfeffer, M.; Andres, H.; Karl, J.; Bodenmüller, H.; Rüschoff, J.; Henkel, T.; Rohr, G.; Rossol, S.; Rösch, W.; Langen, H.; Zolg, W.; Tacke, M. Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer Clin. Cancer Res. 2005, 18, 6550-6557 (Pubitemid 41338994)
14. Dorus, S.; Busby, S. A.; Gerike, U.; Shabanowitz, J.; Hunt, D. F.; Karr, T. L. Genomic and functional evolution of the Drosophila melanogaster sperm proteome Nat. Genet. 2006, 38, 1440-1445 (Pubitemid 44837568)
15. Zhang, B.; Kirov, S.; Snoddy, J. WebGestalt: an integrated system for exploring gene sets in various biological contexts Nucleic Acids Res. 2005, 33, 741-748
16. Zhang, B.; Schmoyer, D.; Kirov, S.; Snoddy, J. GOTree Machine(GOTM): a web-based platform for interpreting sets of interesting genes using Gene Ontology hierarchies BMC Bioinform. 2004, 5, 16
17. Draghici, S.; Khatri, P.; Martins, R. P.; Ostermeier, G. C.; Krawetz, S. A. Global functional profiling of gene expression Genomics 2003, 81, 98-104 (Pubitemid 36298600)
18. Chumbalkar, V. C.; Subhashini, C.; Dhople, V. M.; Sundaram, C. S.; Jagannadham, M. V.; Kumar, K. N.; Srinivas, P. N.; Mythili, R.; Rao, M. K.; Kulkarni, M. J.; Hegde, S.; Hegde, A. S.; Samual, C.; Santosh, V.; Singh, L.; Sirdeshmukh, R. Differential protein expression in human gliomas and molecular insights Proteomics 2005, 4, 1167-1177 (Pubitemid 40469044)
19. Odreman, F.; Vindigni, M.; Gonzales, M. L.; Niccolini, B.; Candiano, G.; Zanotti, B.; Skrap, M.; Pizzolitto, S.; Stanta, G.; Vindigni, A. Proteomic studies on low- and high-grade human brain astrocytomas J. Proteome Res. 2005, 3, 698-708 (Pubitemid 40863258)
20. Orr, L. C.; Fleitz, J.; McGavran, L.; Wyatt-Ashmead, J.; Handler, M.; Foreman, N. K. Cytogenetics in pediatric low-grade astrocytomas Med. Pediatr. Oncol. 2002, 3, 173-177 (Pubitemid 34171071)
21. Sanoudou, D.; Tingby, O.; Ferguson-Smith, M. A.; Collins, V. P.; Coleman, N. Analysis of pilocytic astrocytoma by comparative genomic hybridization Br. J. Cancer 2000, 6, 1218-1222 (Pubitemid 30128882)
22. Chakravarti, A.; Delaney, M. A.; Noll, E.; Black, P. M.; Loeffler, J. S.; Muzikansky, A.; Dyson, N. J. Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas Clin. Cancer Res. 2001, 8, 2387-2395 (Pubitemid 32751640)
23. Hiratsuka, M.; Inoue, T.; Toda, T.; Kimura, N.; Shirayoshi, Y.; Kamitani, H.; Watanabe, T.; Ohama, E.; Tahimic, C. G.; Kurimasa, A.; Oshimura, M. Proteomics-based identification of differentially expressed genes in human gliomas: down-regulation of SIRT2 gene Biochem. Biophys. Res. Commun. 2003, 3, 558-566 (Pubitemid 37083288)
24. Schwartz, S. A.; Weil, R. J.; Johnson, M. D.; Toms, S. A.; Caprioli, R. M. Protein profiling in brain tumors using mass spectrometry: feasibility of a new technique for the analysis of protein expression Clin. Cancer Res. 2004, 3, 981-987 (Pubitemid 38198899)
25. Pfister, S.; Janzarik, W. G.; Remke, M.; Ernst, A.; Werft, W.; Becker, N.; Toedt, G.; Wittmann, A.; Kratz, C.; Olbrich, H.; Ahmadi, R.; Thieme, B.; Joos, S.; Radlwimmer, B.; Kulozik, A.; Pietsch, T.; Herold-Mende, C.; Gnekow, A.; Reifenberger, G.; Korshunov, A.; Scheurlen, W.; Omran, H.; Lichter, P. BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas J. Clin. Invest. 2008, 5, 1739-1749 (Pubitemid 351632377)
26. Senger, D. L.; Tudan, C.; Guiot, M. C.; Mazzoni, I. E.; Molenkamp, G.; LeBlanc, R.; Antel, J.; Olivier, A.; Snipes, G. J.; Kaplan, D. R. Suppression of Rac activity induces apoptosis of human glioma cells but not normal human astrocytes Cancer Res. 2002, 7, 2131-2140 (Pubitemid 34408462)
27. Ding, H.; Roncari, L.; Shannon, P.; Wu, X.; Lau, N.; Karaskova, J.; Gutmann, D. H.; Squire, J. A.; Nagy, A.; Guha, A. Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas Cancer Res. 2001, 9, 3826-3836 (Pubitemid 32695000)
28. Woods, S. A.; Marmor, E.; Feldkamp, M.; Lau, N.; Apicelli, A. J.; Boss, G.; Gutmann, D. H.; Guha, A. Aberrant G protein signaling in nervous system tumors J. Neurosurg. 2002, 3, 627-642 (Pubitemid 34994381)
29. Sahai, E.; Marshall, C. J. RHO GTPases and cancer Nat. Rev. Cancer 2002, 2, 133-142
30. Houry, W. A. Chaperone-assisted protein folding in the cell cytoplasm Curr. Protein Pept. Sci. 2001, 3, 227-244 (Pubitemid 32798793)
31. Lange, S. S.; Vasquez, K. M. HMGB1: the jack-of-all-trades protein is a master DNA repair mechanic Mol. Carcinog. 2009, 7, 571-580
32. Roesli, C.; Borgia, B.; Schliemann, C.; Gunthert, M.; Wunderli-Allenspach, H.; Giavazzi, R.; Neri, D. Comparative analysis of the membrane proteome of closely related metastatic and nonmetastatic tumor cells Cancer Res. 2009, 13, 5406-5414
33. Sharma, A.; Ray, R.; Rajeswari, M. R. Overexpression of high mobility group (HMG) B1 and B2 proteins directly correlates with the progression of squamous cell carcinoma in skin Cancer Invest. 2008, 8, 843-51
34. Lotze, M. T.; DeMarco, R. A. Dealing with death: HMGB1 as a novel target for cancer therapy Curr. Opin. Investig. Drugs 2003, 12, 1405-1409 (Pubitemid 38111202)
35. Koon, N.; Schneider-Stock, R.; Sarlomo-Rikala, M.; Lasota, J.; Smolkin, M.; Petroni, G.; Zaika, A.; Boltze, C.; Meyer, F.; Andersson, L.; Knuutila, S.; Miettinen, M.; El-Rifai, W. Molecular targets for tumour progression in gastrointestinal stromal tumours Gut 2004, 2, 235-40 (Pubitemid 38125511)
36. Rorive, S.; Belot, N.; Decaestecker, C.; Lefranc, F.; Gordower, L.; Micik, S.; Maurage, C. A.; Kaltner, H.; Ruchoux, M. M.; Danguy, A.; Gabius, H. J.; Salmon, I.; Kiss, R.; Camby, I. Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma Glia 2001, 3, 241-55 (Pubitemid 32219133)
37. Cimmino, F.; Schulte, J. H.; Zollo, M.; Koster, J.; Versteeg, R.; Iolascon, A.; Eggert, A.; Schramm., A. Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness Oncogene 2009, 19, 2015-23
38. Camby, I.; Belot, N.; Lefranc, F.; Sadeghi, N.; de Launoit, Y.; Kaltner, H.; Musette, S.; Darro, F.; Danguy, A.; Salmon, I.; Gabius, H. J.; Kiss, R. Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases J. Neuropathol. Exp. Neurol. 2002, 7, 585-596 (Pubitemid 34721463)
39. Järvelä, S.; Rantala, I.; Rodriguez, A.; Kallio, H.; Parkkila, S.; Kinnula, V. L.; Soini, Y.; Haapasalo, H. Specific expression profile and prognostic significance of peroxiredoxins in grade II-IV astrocytic brain tumors BMC Cancer 2010, 22, 100-104
40. Nordfors, K.; Haapasalo, J.; Helén, P.; Paetau, A.; Paljärvi, L.; Kalimo, H.; Kinnula, V. L.; Soini, Y.; Haapasalo, H. Peroxiredoxins and antioxidant enzymes in pilocytic astrocytomas Clin. Neuropathol. 2007, 5, 210-218 (Pubitemid 47403415)
41. The Cancer Genome Atlas Research Network Comprehensive genomic characterisation defines human glioblastoma genes and core pathways Nature 2008, 455, 1061-1068